A recent study by the University of Turku and the University of Helsinki in Finland and the Finnish Social Insurance Institution Kela reveals that the average duration of ADHD medication for children and adolescents is […]
British pharmaceutical giant GlaxoSmithKline announced Wednesday the acquisition of a drug under development to treat a common form of liver disease, in a deal worth up to $2 billion.This article was originally published on MedicalXpress.com
A study published in the Journal of Medicinal Chemistry presents a new family of candidate compounds for the treatment of Alzheimer’s disease and pain, which have shown promising effects in animal models.This article was originally […]
Inhalers have been key to asthma management since the 1950s. The most common, salbutamol, comes in a familiar blue-colored inhaler (or “puffer”).This article was originally published on MedicalXpress.com
Shandong researchers suggest that edible and medicinal fungi contain bioactive components with therapeutic potential for central nervous system (CNS) diseases. Findings offer evidence for the potential of these fungi to serve as novel pharmaceuticals or […]
New research from the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai reveals that patients with moderate-to-severe atopic dermatitis (eczema) who did not initially respond to […]
A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers.This article was originally published on MedicalXpress.com
New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity clinic achieved similar weight loss to that reported in clinical trials—but with less than half […]
A new study has found that phone calls, face-to-face consumer inquiries and out-of-scope questions from staff are the main sources of distraction during the dispensing process in pharmacy settings.This article was originally published on MedicalXpress.com
ADHD stimulant meds don’t increase children’s risk of psychosis, a new study says.This article was originally published on MedicalXpress.com
© 2025 SimplyWell.ca